These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30546956)

  • 1. IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment.
    Perales-Puchalt A; Svoronos N; Villarreal DO; Zankharia U; Reuschel E; Wojtak K; Payne KK; Duperret EK; Muthumani K; Conejo-Garcia JR; Weiner DB
    Oncoimmunology; 2019; 8(1):e1515058. PubMed ID: 30546956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer.
    Che K; Luo Y; Song X; Yang Z; Wang H; Shi T; Wang Y; Wang X; Wu H; Yu L; Liu B; Wei J
    EMBO Mol Med; 2024 Feb; 16(2):251-266. PubMed ID: 38238529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology of the peritoneal cavity: relevance for host-tumor relation.
    Melichar B; Freedman RS
    Int J Gynecol Cancer; 2002; 12(1):3-17. PubMed ID: 11860531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by IL-10 of antigen-induced IL-5 generation, and CD4+ T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity.
    Zuany-Amorim C; Créminon C; Nevers MC; Nahori MA; Vargaftig BB; Pretolani M
    J Immunol; 1996 Jul; 157(1):377-84. PubMed ID: 8683140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies.
    Wagner PL; Knotts CM; Donneberg VS; Dadgar N; Pico CC; Xiao K; Zaidi A; Schiffman SC; Allen CJ; Donnenberg AD; Bartlett DL
    Ann Surg Oncol; 2024 Mar; 31(3):2069-2077. PubMed ID: 37996643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer.
    Hartl CA; Bertschi A; Puerto RB; Andresen C; Cheney EM; Mittendorf EA; Guerriero JL; Goldberg MS
    J Immunother Cancer; 2019 Jul; 7(1):199. PubMed ID: 31362778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
    Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
    Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells.
    Seebauer CT; Brunner S; Glockzin G; Piso P; Ruemmele P; Schlitt HJ; Geissler EK; Fichtner-Feigl S; Kesselring R
    Oncoimmunology; 2016; 5(12):e1242543. PubMed ID: 28439450
    [No Abstract]   [Full Text] [Related]  

  • 9. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation.
    Walker C; Checkel J; Cammisuli S; Leibson PJ; Gleich GJ
    J Immunol; 1998 Aug; 161(4):1962-9. PubMed ID: 9712067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity.
    Ikutani M; Yanagibashi T; Ogasawara M; Tsuneyama K; Yamamoto S; Hattori Y; Kouro T; Itakura A; Nagai Y; Takaki S; Takatsu K
    J Immunol; 2012 Jan; 188(2):703-13. PubMed ID: 22174445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity.
    Yoshida M; Taguchi A; Kawana K; Ogishima J; Adachi K; Kawata A; Nakamura H; Sato M; Fujimoto A; Inoue T; Tomio K; Mori M; Nagamatsu T; Arimoto T; Koga K; Hiraike OW; Oda K; Kiyono T; Osuga Y; Fujii T
    Int J Oncol; 2018 Oct; 53(4):1580-1590. PubMed ID: 30066851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
    Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
    Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors.
    Schaedler E; Remy-Ziller C; Hortelano J; Kehrer N; Claudepierre MC; Gatard T; Jakobs C; Préville X; Carpentier AF; Rittner K
    Vaccine; 2017 Jan; 35(4):577-585. PubMed ID: 28012777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer].
    Rogala E; Nowicka A; Bednarek W; Barczyński B; Wertel I; Zakrzewski M; Kotarski J
    Ginekol Pol; 2012 Jun; 83(6):424-8. PubMed ID: 22880461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin‑33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis.
    Sekiya A; Suzuki S; Tanaka A; Hattori S; Shimizu Y; Yoshikawa N; Koya Y; Kajiyama H; Kikkawa F
    Int J Oncol; 2019 Sep; 55(3):755-765. PubMed ID: 31322193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.
    Haro MA; Dyevoich AM; Phipps JP; Haas KM
    Cancer Res; 2019 Jan; 79(1):159-170. PubMed ID: 30224373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12 Immunomodulation Delays the Onset of Lethal Peritoneal Disease of Ovarian Cancer.
    Cohen CA; Shea AA; Heffron CL; Schmelz EM; Roberts PC
    J Interferon Cytokine Res; 2016 Jan; 36(1):62-73. PubMed ID: 26430781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.
    Péron JM; Bureau C; Gourdy P; Lulka H; Souque A; Calippe B; Selves J; Al Saati T; Bernad J; Cordelier P; Couderc B; Pradayrol L; Pipy B; Buscail L; Vinel JP
    Gut; 2007 Jan; 56(1):107-14. PubMed ID: 16891358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice.
    Jacobsen EA; Doyle AD; Colbert DC; Zellner KR; Protheroe CA; LeSuer WE; Lee NA; Lee JJ
    Allergy; 2015 Sep; 70(9):1148-59. PubMed ID: 26009788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
    Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
    Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.